← Back to Search

Behavioral Intervention

Mobile Health Intervention for Weight Gain Prevention

N/A
Recruiting
Led By Deborah F. Tate, PhD
Research Sponsored by University of North Carolina, Chapel Hill
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 18-39
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights

Study Summary

This trial aims to adapt a weight gain prevention program for young adults in the military using mobile tech to prevent weight gain over 2 years.

Who is the study for?
This trial is for active-duty Air Force members aged 18-39 stationed at select bases, with a BMI of 21-30. Participants must own a smartphone, expect to be at their base for over a year, and be willing to wear a Fitbit daily. Pregnant individuals or those planning pregnancy soon, people who've had weight loss surgery recently or plan to have it, and anyone with past eating disorders or in another weight loss program cannot join.Check my eligibility
What is being tested?
The study tests an mHealth intervention called 'Fit for Duty-mobile' designed to prevent weight gain among young adult military personnel using mobile technology over two years. It adapts an evidence-based approach specifically for this population.See study design
What are the potential side effects?
Since the intervention involves lifestyle changes through mobile health guidance and activity tracking rather than medication, typical medical side effects are not expected. However, participants may experience changes in physical activity patterns.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 39 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Secondary outcome measures
Change in Competence for Diet and Physical Activity
Change in Depression as measured by the CESD-Short Form
Change in Dietary Intake as measured by the ASA-24 hour Recall
+14 more
Other outcome measures
Adoption (Re-AIM)
Effectiveness (Re-AIM)
Implementation (Re-AIM)
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Fit for Duty MobileExperimental Treatment1 Intervention
This arm receives a digital fitness tracker; digital scale; smartphone app which delivers a behavioral weight gain prevention intervention; and periodic coaching calls.
Group II: m-Health ControlActive Control1 Intervention
This arm receives a digital fitness tracker, digital scale, and basic information about behavioral approaches for weight gain prevention.

Find a Location

Who is running the clinical trial?

University of North Carolina, Chapel HillLead Sponsor
1,508 Previous Clinical Trials
4,190,588 Total Patients Enrolled
64 Trials studying Obesity
57,600 Patients Enrolled for Obesity
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,840 Previous Clinical Trials
47,851,670 Total Patients Enrolled
251 Trials studying Obesity
205,602 Patients Enrolled for Obesity
University of VirginiaOTHER
754 Previous Clinical Trials
1,244,619 Total Patients Enrolled
17 Trials studying Obesity
2,078 Patients Enrolled for Obesity

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the upper age limit for enrolling in this experimental protocol?

"Participants must be aged 18-39 in order to meet the trial's eligibility specifications."

Answered by AI

What criteria must be met to be eligible for this clinical trial?

"This medical study is looking for 454 individuals between 18 and 39 years old who have been diagnosed with obesity."

Answered by AI

Are there any openings available for participants in this clinical experiment?

"From the clinicaltrials.gov page, it is clear that this trial has ceased searching for patients as of 10/25/2023 although it first appeared on 11/1/2023. Currently there are 1,062 other studies actively recruiting participants."

Answered by AI
~303 spots leftby Feb 2027